RxDoctor Payments Data

Nathan Ambrose, PA

Surgical · Lafayette, LANPI 1326694076

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 78 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by Abiomed at 41.3% of the total. 2025 is the largest year on record at $1,014, 5.1 times the $201 reported in 2021.

$2,075in general payments, 2019–2025

Across 78 payments — averaging $26.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abiomed$857
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$144
  • Getinge USA Sales, LLC$128
  • Medtronic$115
  • Pacira Pharmaceuticals Incorporated$114
  • ALON Medical Technology$92
  • plus $625 from 18 others

What the payments were for

  • Food & beverage$2,075100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,075 in reported general payments places this provider in the 75th percentile of 130 surgical providers in Louisiana.

See all surgical providers in Louisiana

Medicare billing

Part B allowed, 2024
$17,531
Medicare patients
80
Services billed
179

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban38$21,671
Amiodarone Hcl27$1,799
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen79$545
ClopidogrelClopidogrel Bisulfate49$456
Metoprolol Tartrate102$433
Metoprolol Succinate29$301
Atorvastatin Calcium17$248
Diltiazem 24hr Er (Cd)Diltiazem Hcl11$117
Tramadol Hcl33$90
Warfarin Sodium18$71
Potassium Chloride15$40
Carvedilol14$35
Amlodipine Besylate11$8
Furosemide13$7

Paid to pharmacies, not to this prescriber.

Other surgical in Lafayette

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →